Rotavirus vaccine - Wikipedia, the free encyclopedia
A rotavirus vaccine protects children from rotaviruses, which are the leading cause of severe diarrhoea among infants and young children. [1] Each year more than 500,000 children ...
Rotavirus - Wikipedia, the free encyclopedia
On June 5, 2009, WHO announced that clinical trials of Rotarix vaccine “in high-mortality, low-socioeconomic settings of South Africa and Malawi, found that the vaccine ...
FDA approves Rotarix [Rotavirus Vaccine, live, oral], the first ...
This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates.
Consumer Medicine Information
Consumer Medicine Information ROTARIX ® Rotavirus Vaccine, live attenuated What is in this leaflet? Please read this leaflet carefully before your child receives ROTARIX vaccine.
Rotarix
Rotarix is a vaccine approved to prevent rotavirus, a common cause of severe diarrhea in infants. This eMedTV resource describes how the product works, explains how and when to get ...
FDA approves Rotarix [Rotavirus Vaccine, live, oral], the first ...
About ROTARIX ® ROTARIX is an oral live-attenuated human rotavirus vaccine licensed in more than 100 countries around the world. More than 25 million doses of ROTARIX have been ...
Rotarix – GlaxoSmithKline New Zealand
GlaxoSmithKline markets vaccines to protect against rotavirus gastroenteritis. ... Rotarix ® What Rotarix is used for. Rotarix is a viral vaccine that helps to protect your child against ...
Rotavirus Vaccine
Policy. Aetna considers FDA approved rotavirus vaccines (i.e., Rotateq® and Rotarix®) a medically necessary service for prevention of rotavirus gastroenteritis in infants.
Rotavirus vaccine - Wikipedia, the free encyclopedia
A rotavirus vaccine protects children from rotaviruses, which are the leading cause of severe diarrhoea among infants and young children. [1] Each year more than 500,000 children ...
Rotarix
Rotarix is a viral vaccine marketed by GlaxoSmithKline for the prevention of rotavirus in infants. In April of 2008 Rotarix was approved for use in the United States by the FDA.
